Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model

This study shows that treating damaged donor lungs with mesenchymal stem cells improves lung function and reduces inflammation, leading to lower rates of primary graft dysfunction. This approach may increase the availability of lungs for transplantation and improve outcomes.

The Authors: Edström D, Niroomand A, Stenlo M, Broberg E, Hirdman G, Ghaidan H, Hyllén S, Pierre L, Olm F, Lindstedt S. |

Read the entire publication at PubMed.

---